Phase 1b/2 Trial of Pepinemab Plus Avelumab As Second Line Combination Immunotherapy for Patients with Metastatic Pancreatic Adenocarcinoma.
Journal of Clinical Oncology(2024)
Key words
283-237-267-6887-6888,298-145-222-184-1022,3282-646-4685-2424,130-3426-3529,298-145-222,1880,1880,54,1614,38092-31739
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined